HBeAg阳性慢性HBV感染者血清HBsAg、PTA与吲哚菁绿15分钟滞留率的相关性分析

范文海; 赵正斌; 陈青锋; 张立婷; 王霏霏; 王琼; 王珊; 魏昕

doi:10.3969/j.issn.1001-5256.2016.11.018

HBeAg阳性慢性HBV感染者血清HBsAg、PTA与吲哚菁绿15分钟滞留率的相关性分析

DOI: 10.3969/j.issn.1001-5256.2016.11.018

1. 兰州大学第一临床医学院
2. 兰州大学第一医院东岗院区
3. 兰州大学第一医院

详细信息

中图分类号: R512.62
计量
- 文章访问数: 2530
- HTML全文浏览量: 23
- PDF下载量: 482
- 被引次数: 0
出版历程
- 出版日期: 2016-11-20

Correlation between HBsAg,prothrombin time activity,and indocyanine green retention rate at 15 minutes in patients with HBeAg-positive chronic HBV infection

摘要

摘要: 目的分析HBeAg阳性HBV感染者的HBsAg、PTA和吲哚菁绿15 min滞留率（ICG R15）,并研究三者之间的相关性。方法选取2015年12月-2016年4月兰州大学第一医院收治的HBeAg阳性HBV感染者92例,分为慢性乙型肝炎组（n=24）、肝硬化代偿组（n=38）和肝硬化失代偿组（n=30）。对所有患者进行血清HBsAg定量、PTA及肝脏储备功能ICG R15检测。计数资料组间比较采用χ2检验,计量资料多组间比较采用方差分析,相关性比较采用Pearson相关分析法。结果三组患者血清HBsAg定量比较,差异有统计学意义[（3.82±0.43）log10IU/ml vs（2.88±0.36）log10IU/ml vs（2.60±0.27）log10IU/ml,F=25.19,P<0.001];三组患者的ICG R15比较差异有统计学意义（7.51±3.10）%vs（9.57±8.18）%vs（24.13±14.28）%,F=24.00,P=0.001];三组患者的PTA比较,差异亦有统计学意义[（81.00±17.62）%vs（83.08±9.64）%vs（62.32±...
- 肝炎,乙型,慢性 /
- 肝炎e抗原,乙型 /
- 肝炎表面抗原,乙型 /
- 凝血酶原 /
- 吲哚花青绿
Abstract: Objective To investigate the correlation between HBsAg,prothrombin time activity( PTA),and indocyanine green retention rate at 15 minutes( ICG R15) in patients with HBeAg- positive chronic HBV infection. Methods A total of 92 patients with HBeAg- positive chronic HBV infection who were admitted to The First Hospital of Lanzhou University from December 2015 to April 2016 were enrolled and divided into chronic hepatitis B( CHB) group( 24 patients),compensated liver cirrhosis group( 38 patients),and decompensated liver cirrhosis group( 30 patients). Serum HBsAg quantitation,PTA test,and liver reserve function test( ICG R15)were performed for all patients. The chi- square test was used for comparison of categorical data between groups,an analysis of variance was used for comparison of continuous data between multiple groups,and a Pearson correlation analysis was also performed. Results There were significant differences between the three groups in serum HBsAg quantitation( 3. 82 ± 0. 43 log10 IU / ml vs 2. 88 ± 0. 36 log10 IU / ml vs 2. 60 ± 0. 27 log10 IU / ml,F = 25. 19,P < 0. 001),ICG R15( 7. 51% ± 3. 10% vs 9. 57% ± 8. 18% vs 24. 13% ± 14. 28%,F = 24. 00,P = 0. 001),and PTA( 81. 00% ± 17. 62% vs 83. 08% ± 9. 64% vs 62. 32% ± 16. 90%,F = 13. 42,P = 0. 009). The correlation analysis showed that PTA was negatively correlated with ICG R15 in all three groups( r =- 0. 948,- 0. 602,and- 0. 735,all P < 0. 01). In the compensated liver cirrhosis group and decompensated liver cirrhosis group,HBsAg was positively correlated with PTA( r = 0. 410 and 0. 473,both P < 0. 05) and negatively correlated with ICG R15( r =- 0. 427 and- 0. 768,P < 0. 01). Conclusion In HBeAg positive patients,there are certain correlations between HBsAg,PTA,and ICG R15,which,to a certain degree,reflects the liver reserve function in patients with chronic HBV infection.
- hepatitis B,chronic /
- hepatitis B e antigens /
- hepatitis B surface antigens /
- prothrombin /
- indocyanine green

HTML全文

参考文献(14)

[1]WANG FS,FAN JG,ZHANG Z,et al.The global burden of liver disease:the major impact of China[J].Hepatology,2014,60(6):2099-2108.

[2]Experts in combined team of the major special project of Ministry of Science and Technology supported by China's"Twelfthfive-Yearplan".Management of clinical diagnosis,evaluation,and antiviral therapy for HBV-related cirrhosis[J].Chin J Hepatol,2014,22(5):327-335.(in Chinese)科教部十二五重大专项联合课题组专家.乙型肝炎病毒相关肝硬化的临床诊断、评估和抗病毒治疗的综合管理[J].中华肝脏病杂志,2014,22(5):327-335.

[3] Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association.The guideline of prevention and treatment for chronic hepatitis B:a 2015update[J].J Clin Hepatol,2015,31(12):1941-1960.(in Chinese)中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2015年更新版)[J].临床肝胆病杂志,2015,31(12):1941-1960.

[4]FAN ST.Liver functional reserve estimation:state of the art and relevance for local treatments:the Eastern perspective[J].J Hepatobiliary Pancreat Sci,2010,17(4):380-384.

[5]MARTINOT-PEIGNOUX M,CARVALHO-FILHO R,LAPALUS M,et al.Hepatitis B surface antigen serum level is associated with fibrosis severity in treatment-nave,e antigen-positive patients[J].J Hepatol,2013,58(6):1089-1095.

[6]DONG AA,ZHAO J,JIA JW,et al.Quantitative detection of HBs Ag for evaluation of liver function in patients with chronic hepatitis B[J].World Chin J Dig,2012,20(31):3033-3036.(in Chinese)董爱爱,赵洁,贾建伟,等.HBs Ag定量检测在慢性HBV感染患者肝脏储备功能评价中的作用[J].世界华人消化杂志,2012,20(31):3033-3036.

[7] LUO KX.Hepatitis B basic biology and clinical science[M].4th ed.Beijing:People's Medical Publishing House,2012:41,224.(in Chinese)骆抗先.乙型肝炎基础和临床[M].4版.北京:人民卫生出版社,2012:41,224.

[8]NGUYEN T,THOMPSON AJ,BOWDEN S,et al.Hepatitis B surface antigen levels during the natural history of chronic hepatitis B:a perspective on Asia[J].J Hepatol,2010,52(4):508-513.

[9]LIN LY,WONG VW,ZHOU HJ,et al.Relationship between serum hepatitis B virus DNA and surface antigen with covalently closed circular DNA in HBeA g-negative patients[J].J Med Virol,2010,82(9):1494-1500.

[10]WURSTHOM K,LUTGEHETMANN M,DANDRI M,et al.Peginterferon alpha-2b plus adefovir induce strong ccc DNA decline and HBs Ag reduction in patients with chronic hepatitis B[J].Hepatology,2006,44(3):675-684.

[11] Liver Failure and Artificial Liver Group,Chinese Society of Infectious Diseases,CMA;Severe Liver Diseases and Artificial Liver Group,Chinese Society of Hepatology,CMA.Guideline for diagnosis and treatment of liver failure(2012 version)[J].Chin J Clin Infect Dis,2012,5(6):321-327.(in Chinese)中华医学会感染病学分会肝衰竭与人工肝学组,中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南(2012年版)[J].中华临床感染病杂志,2012,5(6):321-327.

[12]LIU YR,FAN ZP,YANG W,et al.Clinical evaluation of liver storage function by indocyanine green retention test[J].Chin J Hepatol,2010,18(6):476-477.(in Chinese)刘义荣,范作鹏,杨薇,等.吲哚菁绿滞留测试对肝储备功能的评价[J].中华肝脏病杂志,2010,18(6):476-477.

[13]HAN ZQ,ZHU ZH,JI BJ.Prothrombin time,prealbumin,cholesterol,and cholinesterase in patients with severe hepatitis[J].Mod J Integr Tradit Chin West Med,2003,12(23):2591.(in Chinese)韩志启,朱增红,冀宝剑.重症肝炎患者凝血酶原时间、前白蛋白、胆固醇、胆碱酯酶的观察[J].现代中西医结合杂志,2003,12(23):2591.

[14]YANG PL,AITHAGE A,CHUNG J,et al.Immune effectors required for hepatitis B virus clearance[J].Proc Natl Acad Sci U S A,2010,107(2):798-802.

施引文献

资源附件(0)

访问统计